Search by topic:


A weight loss drug repurposed to save lives

post-image

A weight-loss drug could be repurposed to prevent organ failure in patients in intensive care, research from the University of Auckland and Monash University in Australia shows.

Orlistat, marketed in New Zealand as Xenical, can be retooled to treat conditions such as severe acute pancreatitis, severe infection and haemorrhagic shock, according to the study published in the International Journal of Pharmaceutics.

Patent filed. Seeking commercial partners.

https://doi.org/10.1016/j.ijpharm.2021.120247



What do you think?


You must be logged in to post a comment.
Comments
mobiletestshanil @ 2021.02.18 3:06 AM

Good Idea



Related Posts

Healthcare

post-image

Australian cancer patients test the world’s first ‘nanorobot’ antibodies, made in Israel
23 November 2022 by Jeremy Ungar 0 Comments

Healthcare

post-image

Virgin birth: embryos grown without eggs or sperm
13 November 2022 by Trevor Rowe 0 Comments

Healthcare

post-image

Temporary Vasectomies- a world first trial
11 November 2022 by IdeaSpies 0 Comments